Literature DB >> 8325978

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.

G M Reaven1, Y D Chen, J Jeppesen, P Maheux, R M Krauss.   

Abstract

Subjects characterized by a predominance of small LDL particles (pattern B) have changes in plasma triglyceride (TG) and HDL-cholesterol concentrations consistent with the presence of resistance to insulin-mediated glucose uptake. To pursue this issue, plasma glucose and insulin responses to oral glucose, insulin-mediated glucose disposal, and lipoprotein concentrations were measured in subjects categorized on the basis of LDL peak diameter measured by gradient gel electrophoresis. Subjects with pattern B had higher (P < 0.05-0.001) total integrated plasma glucose (20.7 +/- 1.0 mmol/liter.h) and insulin (1,743 +/- 293 pmol/liter.h) responses to oral glucose compared with glucose (16.3 +/- 0.4 and 19.2 +/- 0.8 mmol/liter.h) and insulin (856 +/- 60 and 1,222 +/- 168 pmol/liter.h) responses in those with either pattern A or an intermediate pattern. Pattern B individuals were shown to be more insulin resistant on the basis of higher steady state plasma glucose concentrations (SSPG, 10.4 +/- 1.0, P < 0.002, vs. 7.5 +/- 0.7 and 6.0 +/- 0.4 mmol/liter) after a constant infusion of somatostatin, glucose, and insulin than those with either the intermediate or pattern A subclass. Pattern B subjects also had higher concentrations of (P < 0.001) TG (1.98 +/- 0.15 vs. 1.33 +/- 0.17 and 0.77 +/- 0.05 mmol/liter) and lower (P < 0.01-0.001) HDL cholesterol (1.12 +/- 0.06 vs. 1.34 +/- 0.05 vs. 1.45 +/- 0.05 mmol/liter) than those with either the intermediate or pattern A. Finally, significant (P < 0.001) correlation coefficients existed between LDL diameter and SSPG (r = -0.44); glucose (r = -0.41) and insulin (r = -0.38) responses; TG (r = -0.65) and HDL-cholesterol (r = 0.42) concentrations; and systolic (r = -0.34) and diastolic (r = -0.34) blood pressure. Thus, pattern B subjects are insulin resistant, have higher glucose, insulin, and TG, lower HDL-cholesterol levels, and higher blood pressure than those with pattern A or intermediate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325978      PMCID: PMC293550          DOI: 10.1172/JCI116541

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper- -lipoproteinemia. Demonstration of macromolecular heterogeneity.

Authors:  W R Fisher; M G Hammond; G L Warmke
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

3.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.

Authors:  S W Shen; G M Reaven; J W Farquhar
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

6.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.

Authors:  M A Austin; M C King; K M Vranizan; B Newman; R M Krauss
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

7.  Role of insulin in endogenous hypertriglyceridemia.

Authors:  G M Reaven; R L Lerner; M P Stern; J W Farquhar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

8.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

9.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

Authors:  R M Krauss; D J Burke
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

10.  Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.

Authors:  A L Swislocki; B B Hoffman; W H Sheu; Y D Chen; G M Reaven
Journal:  Am J Med       Date:  1989-01-23       Impact factor: 4.965

View more
  75 in total

Review 1.  Diet and Syndrome X.

Authors:  G M Reaven
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

Review 2.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 3.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

4.  Effects of insulin sensitivity, body composition, and fitness on lipoprotein particle sizes and concentrations determined by nuclear magnetic resonance.

Authors:  Brian A Irving; K Sreekumaran Nair; Manivannan Srinivasan
Journal:  J Clin Endocrinol Metab       Date:  2011-01-26       Impact factor: 5.958

Review 5.  Small, dense low-density lipoprotein: risk or myth?

Authors:  Ngoc-Anh Le
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

Review 6.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 7.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

8.  Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction.

Authors:  Alexis C Frazier-Wood; W Timothy Garvey; Tara Dall; Robert Honigberg; Ray Pourfarzib
Journal:  Metab Syndr Relat Disord       Date:  2012-04-25       Impact factor: 1.894

9.  Thrombophilia in Patients with Hypertriglyceridemia.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 10.  Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Authors:  João Costa; Margarida Borges; Cláudio David; António Vaz Carneiro
Journal:  BMJ       Date:  2006-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.